Literature DB >> 10706799

Epidemiological investigation of Ochrobactrum anthropi strains isolated from a haematology unit.

E Delière1, H Vu-Thien, V Lévy, S Barquins, L Schlegel, A Bouvet.   

Abstract

Ochrobactrum anthropi is an oxidase-producing gram-negative bacillus preferring aqueous environments. It is an opportunist of low pathogenicity with a wide and unpredictable antibiotic resistance. We observed bacteraemia caused by this organism in two immunocompromized patients hospitalized in the same haematology unit and catheter-associated sepsis was recognized within two days. Another isolate was obtained from the stools of a third patient of the same unit. Environmental investigations recovered an isolate from a tap-water sample of the unit. Pulsed-field gel electrophoresis analysis of these four isolates and two others isolates previously found in the same ward, showed identical restriction patterns for the two blood isolates and confirmed that the two bacteraemia were epidemiologically related. Copyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706799     DOI: 10.1053/jhin.1999.0690

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Septic shock caused by Ochrobactrum anthropi in an otherwise healthy host.

Authors:  Adrien Kettaneh; François-Xavier Weill; Isabelle Poilane; Olivier Fain; Michel Thomas; Jean-Louis Herrmann; Laurent Hocqueloux
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi.

Authors:  D Nadjar; R Labia; C Cerceau; C Bizet; A Philippon; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Onchycobacter anthropi Pyomyositis in Immunocompetent Patient: Case Report.

Authors:  Senthil Loganathan; Adnan Qamar; Thyagarajan Umashankar; Gokul Raj Dhanarajan
Journal:  J Orthop Case Rep       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.